Overview

Detailed Summary

TTK Healthcare Limited, part of the TTK Group, offers diversified products across pharmaceuticals, consumer goods, medical devices, and protective devices.
The company has wide geographic exposure with exports to regions including the UK, Egypt, and Caribbean countries, showcasing its global reach.
TTK Healthcare's strategic moves include divesting non-core segments, such as bulk drugs, and acquiring orthopedic implant facilities to strengthen its medical division.
Recent operational changes include recommenced manufacturing at its Virudhunagar facility and product launches to enhance portfolios in various business units.
The company's historic product brands like Woodward's Gripewater and recent additions under 'Skore' reflect continued commitment to brand diversity.

Sector: Diversified
Industry: Diversified
Market Cap: 1,282 Cr
Volatility: Low Risk
P/E Ratio: 21.3
Industry P/E: 32.9
PEG Ratio: 0.3
P/B Ratio: 1.2
52W High: 1,402.00
52W Low: 737.00

Sales CAGR

1Y: 6.47%
3Y: 10.18%
5Y: 4.42%
10Y: 4.94%

Profit CAGR

1Y: 29.95%
3Y: 64.01%
5Y: 45.98%
10Y: 15.30%

ROE

TTM: 6.11%
3Y: 25.97%
5Y: 23.94%
10Y: 20.74%

ROCE

TTM: 7.79%
3Y: 8.75%
5Y: 8.64%
10Y: 10.29%

Technicals

‌

Forecasts

Peers

Diversified Diversified Diversified Diversified

Symbol	Watchlist	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
TTKHLTCARE		781.45	1,269 Cr	21.12	1.17	1.11	6.11	7.79	4.64
DVL		237.40	855 Cr	-41.87	0.26	2.05	1.64	3.02	-0.55
EMPIND		869.95	545 Cr	14.72	1.68	2.75	11.36	11.50	4.58
SPCENET		3.28	240 Cr	14.98	1.45	0.00	8.82	9.66	7.69
ADANIENPP1		1719.00	179 Cr	—	0.01	0.00	—	—	0.00
ASPINWALL		218.80	178 Cr	18.94	0.95	2.85	0.99	2.91	2.99
MAHESHWARI		50.37	150 Cr	7.52	0.72	0.00	9.05	12.11	3.08
Median: 7 Co.	—	237.40	240 Cr	14.85	0.95	1.11	7.47	8.73	3.08

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

Ask AI

Standalone Quarterly Results (in ₹ Crores)

Total Figures

QoQ Changes

Total Figures

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Sales	186	184	181	208	198	205	190	226	204	209
Expenses	176	179	169	201	190	197	178	224	198	202
Operating Profit	9.54	5.34	12	6.90	8.23	7.69	12	2.68	5.33	7.14
OPM %	5.14	2.90	6.86	3.32	4.15	3.76	6.31	1.18	2.62	3.41
Other Income	16	16	16	37	18	18	13	18	19	9.85
Interest	0.73	0.23	0.93	0.86	0.74	0.82	0.90	0.77	0.84	0.68
Depreciation	3.28	3.31	3.32	2.05	2.00	2.11	2.17	2.19	2.21	2.22
Profit Before Tax	22	18	24	41	23	23	22	18	21	14
Tax %	25.74	27.18	24.56	22.60	25.83	25.94	25.78	26.35	4.27	25.20
Net Profit	16	13	18	32	17	17	16	13	20	11
EPS in Rs	11.33	9.13	12.93	22.35	12.17	11.84	11.43	9.20	14.43	7.45

Standalone Profit Loss (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	528	578	628	646	476	599	725	753	801	820
Expenses	489	535	578	617	457	577	694	715	767	789
Operating Profit	38	43	50	28	19	22	31	37	35	31
OPM %	7.29	7.37	7.89	4.38	4.06	3.64	4.32	4.96	4.35	3.73
Other Income	5.73	7.57	7.75	8.78	18	19	48	63	85	66
Interest	3.11	4.73	3.38	3.27	1.71	3.24	5.24	2.76	3.32	3.23
Depreciation	12	15	15	14	13	13	13	13	8.33	8.47
Profit Before Tax	29	30	39	19	23	25	62	84	108	85
Tax %	35.77	39.74	37.92	36.58	-62.60	25.47	27.53	25.30	24.62	25.95
Net Profit	19	18	24	12	37	19	45	63	82	63
EPS in Rs	13.26	17.09	17.26	8.73	32.86	29.43	452.73	44.48	57.79	42.51
Dividend Payout %	20.72	38.88	28.99	34.40	18.25	33.98	2.21	22.49	17.30	—

Standalone Balance Sheet (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	7.77	7.77	14	14	14	14	14	14	14	14
Reserves	128	150	219	237	235	281	316	939	987	1,051
Borrowings	23	23	47	28	30	19	22	27	23	24
Other Liabilities	143	105	127	136	152	180	207	189	177	192
Total Liabilities	303	285	407	416	431	494	559	1,170	1,201	1,281
Fixed Assets	106	99	110	98	89	85	80	71	75	81
CWIP	0.85	0.25	0.79	1.54	8.77	0.45	0.19	2.79	0.79	0.08
Investments	10	8.83	9.26	13	8.75	13	15	13	13	11
Other Assets	185	177	288	304	325	395	463	1,083	1,112	1,189
Total Assets	303	285	407	416	431	494	559	1,170	1,201	1,281

Standalone Cash Flows (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	37	18	25	17	20	96	45	-25	-4.94	-3.98
Cash from Investing Activity	-27	5.26	-22	9.65	-13	-77	-30	32	28	20
Cash from Financing Activity	-11	-23	-7.20	-31	-10	-17	-10	-12	-22	-18
Net Cash Flow	-0.16	0.13	-4.12	-3.77	-3.63	2.03	5.31	-5.54	1.64	-1.95

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Promoters	74.56%	74.56%	74.56%	74.56%	74.56%	74.56%	74.56%	74.56%	74.56%	74.56%	74.56%	74.56%
FIIs	2.40%	1.85%	1.85%	1.85%	1.87%	1.90%	1.90%	1.90%	1.89%	1.90%	1.89%	1.90%
DIIs	3.27%	3.22%	3.13%	1.14%	1.14%	1.14%	1.14%	1.14%	1.18%	1.18%	1.08%	1.11%
Public	19.76%	20.36%	20.45%	22.45%	22.43%	22.40%	22.40%	22.40%	22.37%	22.36%	22.46%	22.43%
Total Shareholders	16,109	15,672	16,651	17,221	16,930	15,762	15,780	15,899	16,112	16,134	22,481	23,686

Market Transactions

Unlock more with professional

Real-time bulk & block deal transactions
Export transaction data for analysis

Projection

Documents

Presentations

Concalls

Reports

Presentations

Investor Presentation

Q1 FY17

Actions

Action Type

‌
‌

Announcements

Last 7 days

Newest

Sentiment

Sorry, no results found!

AI Mode

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.